Search Results - "Verdugo, Ramón Morillo"

Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain by Cantudo-Cuenca, M. D., Gutiérrez-Pizarraya, Antonio, Pinilla-Fernández, Ana, Contreras-Macías, Enrique, Fernández‑Fuertes, M., Lao‑Domínguez, F. A, Rincón, Pilar, Pineda, Juan Antonio, Macías, Juan, Morillo-Verdugo, Ramón

“…Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID-19 and concomitant medications…”
Get full text

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection by Sicras-Mainar, Antoni, Morillo-Verdugo, Ramón

“…Objective To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in…”
Get full text

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment by Macías, Juan, Pinilla, Ana, Lao-Dominguez, Francisco A., Corma, Anaïs, Contreras-Macias, Enrique, González-Serna, Alejandro, Gutierrez-Pizarraya, Antonio, Fernández-Fuertes, Marta, Morillo-Verdugo, Ramón, Trigo, Marta, Real, Luis M., Pineda, Juan A.

“…The impact of drug–drug interactions (DDI) between ritonavir-boosted lopinavir (LPV-r) to treat patients with coronavirus disease 2019 (COVID-19) and commonly…”
Get full text

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy by Macías, Juan, González-Moreno, Paz, Sánchez-García, Esther, Morillo-Verdugo, Ramón, Pérez-Venegas, José J, Pinilla, Ana, Macho, MªMar, Martínez, MªVictoria, González-Serna, Alejandro, Corma, Anaïs, Real, Luis M, Pineda, Juan A

“…Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure…”
Get full text

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain by Morillo Verdugo, Ramón, Ramírez Herráiz, Esther, Fernández-Del Olmo, Raquel, Roig Bonet, Montserrat, Valdivia García, María

“…Adherence to disease-modifying treatments is essential in order to maximize the beneficial effects of treatment for multiple sclerosis (MS). There are numerous…”
Get full text

Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort by Contreras Macías, E, Serrano Giménez, R, Morillo Verdugo, R

“…We assessed the prevalence of potentially inappropriate prescriptions (PIP) among older (≥ 65 years) people living with HIV (PLWHIV). Additionally, the…”
Get full text

Usability and Acceptability of a Comprehensive HIV and Other Sexually Transmitted Infections Prevention App by Rodríguez Vargas, Blanca, Sánchez-Rubio Ferrández, Javier, Garrido Fuentes, Jorge, Velayos, Reyes, Morillo Verdugo, Ramón, Sala Piñol, Ferrán, Onteniente González, Alberto, Rodríguez Sagrado, Miguel Ángel

“…The Preparadxs app was designed to enhace the prevention of the HIV and other sexually transmitted infections transmission through the empowerment of the user…”
Get full text

Influence of pharmacotherapy complexity on compliance with the therapeutic objectives for HIV+ patients on antiretroviral treatment concomitant with therapy for dyslipidemia. INCOFAR Project by Galán, Rocío Jiménez, Escalante, Inés María, Verdugo, Ramón Morillo

“…To analyze the relationship between pharmacothe-rapeutical complexity and compliance of therapeutic objectives in HIV+ patients on antiretroviral treatment and…”
Get full text

Relationship between pharmacotherapy complexity and patient satisfaction with treatment for hepatitis C by Cortés, María de las Aguas Robustillo, González, Carmen Victoria Almeida, Verdugo, Ramón Morillo

“…To establish the relationship between the complexity of treatment for hepatitis C and patient satisfaction. An observational, prospective, single-center study,…”
Get full text

High quantity but limited quality in healthcare applications intended for HIV-infected patients by Robustillo Cortés, María de las Aguas, Cantudo Cuenca, María Rosa, Morillo Verdugo, Ramón, Calvo Cidoncha, Elena

“…The aim of this study was to evaluate, through the creation of a specific questionnaire, the information quality in mobile applications (apps) aimed at human…”
Get more information

Influence of hospital admission in the pharmacotherapy complexity of HIV+ patients by Cortés, María de las Aguas Robustillo, Verdugo, Ramón Morillo, Fernández, Esther María Barreiro, Plata, Ascensión Pavón, Agudo, Patricia Monje

“…To determine the variation in the pharmacotherapy complexity index in HIV+ patients after hospital admission. A retrospective, single-center study with HIV+…”
Get full text

Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model by Verdugo, Ramón Morillo, Arévalo, Andrea Lisbeth Villarreal, Sotomayor, María Álvarez de, Cortes, María de las Aguas Robustillo

“…To agree on a proposal for pharmaceutical interventions and establish their classification taxonomy according to the CMO-Pharmaceutical Care Model…”
Get full text

Concomitant use of direct-acting antivirals (DAA) and central nervous system drugs in patients with hepatitis C virus infection by Sicras-Mainar, Antoni, Morillo-Verdugo, Ramón

“…Our objective was to determine potential drug interactions (DI) between pangenotypic direct-acting antivirals (pDAA) and concomitant central nervous system…”
Get full text

[Translated article] Precision pharmaceutical care in oncohematology by Morillo-Verdugo, Ramón, Lizeaga-Cundin, Garbiñe

Get full text

Influence of the Type of Antiretroviral Treatment on the Time to Reach High Pharmacotherapy Complexity in People Living With HIV by Contreras Macías, Enrique, Robustillo Cortés, María de Las Aguas, Blanco Ramos, José Ramón, Morillo Verdugo, Ramón

“…The introduction of antiretroviral therapy (ARV) has significantly improved the survival of people living with HIV (PLWH), increasing the proportion of…”
Get full text

Concomitant use of direct-acting antivirals (DDAs) and central nervous system drugs in current chronic hepatitis C patient profile by Sicras, Antoni, Verdugo, Ramón Morillo

Get full text

THU395 - Concomitant use of direct-acting antivirals (DDAs) and central nervous system drugs in current chronic hepatitis C patient profile by Sicras, Antoni, Verdugo, Ramón Morillo

Get full text

Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B by Borrego Izquierdo, Yolanda, Gómez Fernández, Encarnación, Monje Agudo, Patricia, Jiménez Galán, Rocío, Almeida-González, Carmen V, Ferrit Martín, Mónica, Morillo Verdugo, Ramón

“…BackgroundThere are currently five approved nucleos(t)ide analogues (NUCs) for the management of chronic hepatitis B (CHB): lamivudine, adefovir dipivoxil,…”
Get full text

Correlates of one-year mortality among patients living with HIV according to the stratification level of the pharmaceutical care model by Contreras-Macías, Enrique, Robustillo-Cortés, María de las Aguas, Morillo-Verdugo, Ramón

“…The patient living with HIV (PLWH) profile has changed and with it, the importance of patient-oriented pharmaceutical care (PC) has been highlighted, for which…”
Get full text

Drug burden index in people living with HIV over 50 years of age in a real clinical practice cohort by Lao-Domínguez, Francisco Ángel, Robustillo-Cortés, María de las Aguas, Morillo-Verdugo, Ramón

“…To determine DBI and its relationship with polypharmacy and pharmacotherapeutic complexity (PC) in a cohort of PLWH over 50 years of age at follow-up of…”
Get full text